Improved treatment of cancer with glutamine

Details for Australian Patent Application No. 2003257963 (hide)

International Classifications

Event Publications

13 November 2003 Complete Application Filed

Priority application(s): 60/400,446 01.08.02 US

1 April 2004 Application Open to Public Inspection

Published as AU-B-2003257963

24 April 2008 Assignment before Grant

Board of Trustees of the University of Arkansas; Aesgen, Inc. The application has been assigned to Board of Trustees of the University of Arkansas; MGI Pharma Inc.

5 March 2009 Assignment before Grant

MGI Pharma Inc.; Board of Trustees of the University of Arkansas The application has been assigned to Eisai Corporation of North America; Board of Trustees of the University of Arkansas

13 August 2009 Application Accepted

Published as AU-B-2003257963

10 December 2009 Standard Patent Sealed

3 June 2010 Assignment Registered

Board of Trustees of the University of Arkansas; Eisai Corporation of North America The patent has been assigned to Board of Trustees of the University of Arkansas; Eisai Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.